Device type · CAZ
Anesthesia Conduction Kit
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
CAZ
Anesthesiology
Device class
Class II
FDA decisions since 2015
9
510(k), De Novo and PMA
Adverse event reports
109
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Anesthesia Conduction Kit
- Product code
- CAZ
- Device class
- Class II
- Review panel
- Anesthesiology
- Regulation
- 21 CFR 868.5140
- Specialty
- Anesthesiology & Respiratory
- FDA record
- Classification database entry for CAZ
Latest FDA decisions
The 8 newest of 9 since 2015.
- Profoject LOR Syringe510(k)
K261372 · Decided Sep 25, 2026 · 151 days after receipt
Device type: Anesthesia Conduction Kit (CAZ) · Anesthesiology & Respiratory
K222341 · Decided Feb 13, 2023 · 194 days after receipt
Device type: Anesthesia Conduction Kit (CAZ) · Anesthesiology & Respiratory
- BD Epilor Syringe510(k)
K210983 · Decided May 19, 2022 · 413 days after receipt
Device type: Anesthesia Conduction Kit (CAZ) · Anesthesiology & Respiratory
6 more FDA decisions with a free account
Reports received
109
Received Nov 1, 2025 to Nov 19, 2026. Includes 1 of another or unstated type.
Malfunction reports
74
68% of reports
Injury reports
34
31% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 1 | 1 | 0 | 0 |
| Jan 24 | 8 | 3 | 0 | 0 |
| Feb 24 | 5 | 7 | 0 | 0 |
| Mar 24 | 3 | 2 | 0 | 0 |
| Apr 24 | 6 | 1 | 0 | 0 |
| May 24 | 4 | 2 | 0 | 0 |
| Jun 24 | 8 | 1 | 0 | 1 |
| Jul 24 | 20 | 8 | 0 | 0 |
| Aug 24 | 12 | 2 | 0 | 0 |
| Sep 24 | 18 | 2 | 0 | 0 |
| Oct 24 | 11 | 1 | 0 | 0 |
| Nov 24 | 11 | 6 | 0 | 0 |
| Dec 24 | 18 | 5 | 0 | 0 |
| Jan 25 | 5 | 0 | 0 | 0 |
| Feb 25 | 5 | 1 | 0 | 0 |
| Mar 25 | 15 | 1 | 0 | 0 |
| Apr 25 | 9 | 3 | 0 | 0 |
| May 25 | 6 | 3 | 0 | 0 |
| Jun 25 | 5 | 3 | 0 | 0 |
| Jul 25 | 8 | 10 | 0 | 0 |
| Aug 25 | 9 | 2 | 0 | 0 |
| Sep 25 | 8 | 3 | 0 | 0 |
| Oct 25 | 21 | 1 | 0 | 0 |
| Nov 25 | 6 | 3 | 0 | 0 |
| Dec 25 | 9 | 2 | 0 | 0 |
| Jan 26 | 3 | 0 | 0 | 0 |
| Feb 26 | 4 | 2 | 0 | 0 |
| Mar 26 | 5 | 3 | 0 | 0 |
| Apr 26 | 14 | 5 | 0 | 0 |
| May 26 | 7 | 6 | 0 | 0 |
| Jun 26 | 10 | 4 | 0 | 0 |
| Jul 26 | 6 | 1 | 0 | 0 |
| Aug 26 | 2 | 2 | 0 | 0 |
| Sep 26 | 5 | 5 | 0 | 1 |
| Oct 26 | 3 | 1 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- Teleflex20
7 more in this ranking with a free account
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Fluid/Blood Leak21
- Break18
- Detachment of Device or Device Component11
7 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions66
- Foreign Body In Patient19
- Insufficient Information8
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2248-2026 · Started Apr 27, 2026 · Posted by FDA May 29, 2026
Reason given: This is a sub-recall of a product recall from Huons Co, Ltd., the manufacturer of Bupivacaine Hydrochloride in Dextrose Injection, USP. The recall is due to quality issues identified during an FDA manufacturing facility inspection, citing specific quality deficiencies related to acceptance testing.
Cause as FDA categorized it: Nonconforming Material/Component
Z-2249-2026 · Started Apr 27, 2026 · Posted by FDA May 29, 2026
Reason given: This is a sub-recall of a product recall from Huons Co, Ltd., the manufacturer of Bupivacaine Hydrochloride in Dextrose Injection, USP. The recall is due to quality issues identified during an FDA manufacturing facility inspection, citing specific quality deficiencies related to acceptance testing.
Cause as FDA categorized it: Nonconforming Material/Component
Z-2250-2026 · Started Apr 27, 2026 · Posted by FDA May 29, 2026
Reason given: This is a sub-recall of a product recall from Huons Co, Ltd., the manufacturer of Bupivacaine Hydrochloride in Dextrose Injection, USP. The recall is due to quality issues identified during an FDA manufacturing facility inspection, citing specific quality deficiencies related to acceptance testing.
Cause as FDA categorized it: Nonconforming Material/Component
217 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.